Annotation Detail

Information
Associated Genes
MLH1
Associated Variants
MLH1 METHYLATION
MLH1 METHYLATION
Associated Disease
stomach carcinoma
Source Database
CIViC Evidence
Description
The methylation status of MLH1 was analyzed in a study of 53 paraffin-embedded gastric cancer samples. No association was found between methylation status and clinical factors. The study showed that MLH1 methylation was associated with resistance to treatment with oxaliplatin.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1315
Gene URL
https://civic.genome.wustl.edu/links/genes/3532
Variant URL
https://civic.genome.wustl.edu/links/variants/538
Rating
2
Evidence Type
Predictive
Disease
Stomach Carcinoma
Evidence Direction
Supports
Drug
Oxaliplatin
Evidence Level
B
Clinical Significance
Resistance
Pubmed
24748501
Drugs
Drug NameSensitivitySupported
OxaliplatinResitance or Non-Reponsetrue